RIC Remote Ischemic Conditioning to reduce reperfusion injury during acute STEMI: A systematic review and meta-analysis
|
|
- Camilla Cunningham
- 6 years ago
- Views:
Transcription
1 RIC Remote Ischemic Conditioning to reduce reperfusion injury during acute STEMI: A systematic review and meta-analysis [McLeod SL, Iansavitchene A, Cheskes S] Sheldon Cheskes, MD CCFP(EM) FCFP Medical Director, Sunnybrook Centre for Prehospital Medicine Associate Professor, Division of Emergency Medicine, University of Toronto Scientist, Li Ka Shing Knowledge Institute, St. Michael s Hospital Co-Principal Investigator, Toronto RescuNet, Resuscitation Outcomes Consortium Disclosure Financial Disclosure: CIHR/NIH funding Resuscitation Outcomes Consortium Speakers Honorarium CPR Quality (Zoll Medical/ Physio-Control) Unlabeled/Unapproved Uses Disclosure: none Conflicts of Interest: none Background Remote ischemic conditioning (RIC) is a non-invasive strategy to minimize reperfusion injury in ischemic conditions 1
2 Remote Ischemic Conditioning Kharbanda RK et al. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009;374: Background Recent RCTs suggest no benefit in CABG Previous RCTs suggest a benefit in some surrogate markers for STEMI No meta-analysis or systematic review has assessed the impact of RIC in STEMI as the sole ischemic condition Research Question Does remote ischemic conditioning (RIC) initiated prior to PCI for STEMI reduce reperfusion injury? 2
3 Inclusion Criteria Study Design RCTs published in English Participants STEMI patients, no age restriction Intervention/Comparison RIC prior to balloon inflation (± post RIC) vs PCI alone Outcomes of Interest Primary Outcome Myocardial salvage index (proportion of area at risk of the left ventricle salvaged by treatment following emergent PCI) Secondary Outcomes Infarct size and major adverse cardiovascular events (MACE) Search Strategy Electronic search of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials 2 reviewers independently screened titles and abstracts and assessed study quality Hand search of reference lists of relevant articles Grey literature, conference abstracts included 3
4 Methods Data pooled using random-effects models and reported as risk ratios (RR) with 95% confidence intervals (CIs) where appropriate Grading of Recommendations, Assessment, Development and Evaluation criteria used to evaluate quality of evidence Trial Search and Eligibility Process Titles/abstracts acquired from search (n = 643) Titles/abstracts screened (n = 348) Potentially relevant studies retrieved in full text (n = 30) Trials included in systematic review (n = 11) Duplicate articles (n = 295) Articles did not meet eligibility criteria (n = 318) Excluded (n = 19) Kappa = 0.93 (95% CI: 0.81, 1.0) RIC Control Trial Inclusion Criteria RIC Protocol n n Botker 18 years, symptom (2010) 4 5 min cycles of RIC in ambulance onset <12h, STEMI Denmark 3 x 5 min cycles of RIC on arrival to PCI lab (RIC) Eitel 158 RIC and post RIC Symptom onset Followed by 4 x 30 second cycles post stent deployment (post RIC) (2015) 160 <12h STEMI 3 arm trial Germany 173 post RIC RIC alone vs RIC and post RIC vs control (PCI only) Liu STEMI, symptom onset (2016) 4 5 min cycles of RIC in ambulance <12h, 18 years Mongolia Manchurov Acute Myocardial (2014) Infarction 4 5 min cycles of RIC prior to PCI Russia (45 STEMI, 3 NSTEMI) Munk 18 years, symptom (2010) 4 5 min cycles of RIC in ambulance onset <12h, STEMI Denmark Prunier 3 5 min cycles of RIC on arrival 36 RIC 18 years, symptom (2014) 44 onset <6h, STEMI France RIC and post RIC 71 RIC and post RIC 3 4 min cycles of RIC on arrival to hospital Rentoukas 35 to 75 years, 33 RIC (2010) symptom onset RIC with morphine infusion 5 min. prior PCI 30 Greece <6h STEMI 33 RIC and morphine PCI (Sham RIC inflated to a pressure <DBP and saline infusion) Sloth 18 years, symptom (2013) 4 5 min cycles of RIC in ambulance onset <12h, STEMI Denmark Verouhis STEMI, symptom onset 1 x 5 min cycles of RIC on arrival followed by (2016) <6h, 18 years 4 x 5 min cycles of RIC post reperfusion Sweden White 18 to 80 years, 4 5 min cycles of RIC on arrival to hospital (2015) symptom onset UK <12h STEMI PCI alone (uninflated cuff placed on upper arm for 40 min.) Yamanaka 3 5 min cycles of RIC on arrival to hospital 20 years, symptom (2015) onset <24h, STEMI Japan PCI alone (uninflated cuff placed on upper arm for 30 min.) 4
5 Results 11 articles (9 RCTs) included Total of 1,220 individual patients 643 in the RIC+PCI group 577 in the PCI group All 9 RCTs were conducted outside of North America 7 trials used standard manual, BP cuff on the upper limb, 1 lower limb and 1 automated BP cuff for the delivery RIC 2 initiated RIC in the ambulance, 7 RIC initiated on arrival to hospital (prior to PCI) Assessment of Risk of Bias Myocardial Salvage Index RR 0.08 (0.02 to 0.14) 636 5
6 Infarct Size RR (-4.66 to -0.26) 848 (5 studies) MACE 9.5% in the RIC+PCI group compared to 17.0% PCI alone RR 0.57 (0.40 to 0.82) 928 Mortality 4.5% in the RIC+PCI group compared to 7.8% PCI alone RR 0.50 (0.20 to 1.23) 928 6
7 Reinfarction 2.4% in the RIC+PCI group compared to 2.8% PCI alone RR 0.83 (0.38 to 1.82) 928 low Heart Failure 2.2% in the RIC+PCI group compared to 5.4% PCI alone RR 0.41 (0.20 to 0.84) 928 Limitations No North American or non-english studies included Combination of pre- and post-conditioning studies Lack of blinding of participants and personnel (performance bias) Significant loss to follow up for primary end points for imaging studies (attrition bias) Lack of studies focusing on clinically-based outcomes Variable length of follow up for MACE and mortality 7
8 Conclusions RIC appears to be beneficial to infarct size and myocardial salvage index when provided prior to PCI No statistical benefit to death or reinfarction but benefit shown to rates of heart failure at 6 months Findings regarding MACE and clinical outcomes impacted by length of follow up in each study Conclusions RIC is emerging as a promising adjunctive treatment to PCI for the prevention of reperfusion injury in STEMI patients Future multicenter clinical studies will help elucidate the effect of RIC on clinical outcomes such a hospitalization, heart failure and mortality Thank You 8
Disclosure. Co-investigators 1/23/2015
The impact of chest compression fraction on clinical outcomes from shockable out-of-hospital cardiac arrest during the ROC PRIMED trial Sheldon Cheskes, MD CCFP(EM) FCFP Medical Director, Sunnybrook Centre
More informationImproving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark
Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The
More informationPathophysiology of ischemia-reperfusion injury (and how to protect against it )
Pathophysiology of ischemia-reperfusion injury (and how to protect against it ) Dr Derek J Hausenloy Reader in Cardiovascular Medicine BHF Senior Clinical Research Fellow Honorary Consultant Cardiologist
More informationFacilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?
Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at
More informationEffectiveness of CDM-KT strategies addressing multiple high-burden chronic diseases affecting older adults: A systematic review
Effectiveness of CDM-KT strategies addressing multiple high-burden chronic diseases affecting older adults: A systematic review Monika Kastner, Roberta Cardoso, Yonda Lai, Victoria Treister, Joyce Chan
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationPrimary Percutaneous Coronary Intervention
The big 5 in PCI Primary Percutaneous Coronary Intervention W. Wijns (Aalst, BE) Disclosures Consulting Fees: on my behalf go to the Cardiovascular Research Center Aalst Contracted Research between the
More informationSTEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia.
STEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia. PART 1 Systems of care for STEMI. STEMI Management Coronary angiogram +/- stenting. Prehospital thrombolysis
More informationBorja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Fundación Jiménez Díaz Hospital.
STEMI 1: Timing, Mechanical Type and Pharmacology of Reperfusion: The Three Main Challenges to Decrease Infarct Size and Increase Viability Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones
More informationAmerican Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
More informationRevived indications for thrombus aspiration during primary PCI: Unanswered questions after TAPAS
Revived indications for thrombus aspiration during primary PCI: Unanswered questions after TAPAS Gregg W. Stone MD Columbia University Medical Center Cardiovascular Research Foundation Disclosures Gregg
More informationPresented by Prof David Erlinge, MD, PhD, On behalf of the RAPID MI-ICE Investigators
Cold saline and endovascular cooling induces rapid hypothermia before reperfusion in STEMI patients treated with primary PCI, is safe and reduces infarct size with a scattered myocardial salvage Presented
More informationRemote ischemic conditioning in the STEMI and stroke: are we ready for clinical implementation?
Remote ischemic conditioning in the STEMI and stroke: are we ready for clinical implementation? Hans Erik Bøtker, MD, Ph.D. Aarhus University Hospital Skejby Denmark ACC Rockies 2013 17. March 2013 Presenter
More informationSTEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology
STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post
More informationPatient and System Time Delay
Quality Indicators in the Management of ST-elevation Myocardial Infarction Patient and System Time Delay Jacob Thorsted Sorensen, MD, PhD Department of Cardiology Aarhus University Hospital, Denmark Disclosures
More informationPatient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis
More informationCritical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto
Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death Debra Moy Faculty of Pharmacy University of Toronto Goal To provide practitioners with a systematic approach to evaluating a meta analysis
More informationIs the role of bivalirudin established?
Is the role of bivalirudin established? Rob Henderson Consultant Cardiologist Trent Cardiac Centre Nottingham University Hospitals Conflicts of Interest: None Declarations: Member NICE Unstable Angina
More informationConflict of interest :None. Meta-analysis. Zhangwei Chen, MD
Meta-analysis Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis after Drug-Eluting Stent Implantation Zhangwei Chen, MD Department of Cardiology,
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationBMS vs. DES vs. CABG
A Collaborative Systemic Review and Meta-Analysis of A Results from 3976 Patients: BMS vs. DES vs. CABG Overall Safety and Efficacy Issues of Left Main Intervention Duk-Woo Park, MD, PhD University of
More informationSTEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury.
STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Hospital Clínico San Carlos.
More informationPiCSO to Improve Myocardial Salvage and Reduce Infarct Size in STEMI: Emerging Data
PiCSO to Improve Myocardial Salvage and Reduce Infarct Size in STEMI: Emerging Data Azfar G. Zaman, MD Freeman Hospital, Newcastle upon Tyne, UK Disclosure Statement of Financial Interest Within the past
More informationCurrent Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach
Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants
More informationLiterature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction
Literature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction EMS Bureau Protocol Review Steering Committee Background In 2009, approximately 683,000 Americans
More informationFacilitated Percutaneous Coronary Intervention in STEMI Patients: Does It Work in Asian Patients?
Editorial Comment Acta Cardiol Sin 2014;30:292 297 Facilitated Percutaneous Coronary Intervention in STEMI Patients: Does It Work in Asian Patients? Wei-Chun Huang, 1,2,3 Cheng-Hung Chiang 1,2 and Chun-Peng
More informationBivalirudin should be indicated for all patients with STEMI. Adnan Kastrati Deutsches Herzzentrum, Munich, Germany
Bivalirudin should be indicated for all patients with STEMI Adnan Kastrati Deutsches Herzzentrum, Munich, Germany 1 Heparin+IIb/IIIa, heparin alone or bivalirudin in STEMI: Do we have the answer? 2 Heparin+IIb/IIIa,
More informationThe Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium
The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications
More informationSummary HTA. Drug-eluting stents vs. coronary artery bypass-grafting. HTA-Report Summary. Gorenoi V, Dintsios CM, Schönermark MP, Hagen A
Summary HTA HTA-Report Summary Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease Gorenoi V, Dintsios CM, Schönermark MP, Hagen A Scientific background The coronary heart
More informationRecommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies
Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationResolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationEXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017
EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts
More informationThe Strategic Reperfusion Early After STEMI study Implications for clinical practice
The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional
More informationPrevention of reperfusion injury in STEMI - Contra
Prevention of reperfusion injury in STEMI - Contra Prof David Erlinge, MD, PhD Lund University, Skane University Hospital, Lund Sweden Disclosure statement: Received speakers fees from the Medicines company,
More informationPrognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction
Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction Holger Thiele, MD; Konrad Kubusch, BSc; Steffen Desch,
More informationMission: Lifeline Addressing the System of STEMI Care
Mission: Lifeline Addressing the System of STEMI Care Alice K. Jacobs, M.D. Boston University Medical Center Boston, MA, USA ACC West Virginia Chapter, April 2017 Disclosure Information FINANCIAL DISCLOSURE:
More informationManagement of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police
Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis
More informationPCI Update Qesaria 2009
PCI Update Qesaria 2009 Amit Segev Interventional Cardiology Chaim Outline Primary PCI Non-ST elevation ACS Multi-vessel disease Hemodynamic assessment of borderline lesions - FFR Stable AP Non-coronary
More informationPharmaco-Invasive Approach for STEMI
Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),
More informationNEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association
NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.
More informationKCS Congress: Impact through collaboration
STEMI IN A NEW INTERVENTIONAL ENVIRONMENT Harun A Otieno, FACC June 29th, 2017 KCS Congress: Impact through collaboration Disclosures I have no conflicts of interest for this talk I have no relationships
More informationAcute Coronary Syndrome
Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with
More informationNuovi target e opportunità terapeutiche del danno da riperfusione nello STEMI
GUIDATI DA PARADIGMI SEMPRE NUOVI, GLI SCIENZIATI ADOTTANO NUOVI STRUMENTI E PROGETTANO NUOVI STUDI GUARDANDO VERSO NUOVE DIREZIONI Nuovi target e opportunità terapeutiche del danno da riperfusione nello
More informationDanish registry of ACS DANAMI Studies Peter Clemmensen, MD, DMSc, FESC, FSCAI Thomas Engstrøm, MD, PhD, DMSc
Danish registry of ACS DANAMI Studies Peter Clemmensen, MD, DMSc, FESC, FSCAI Thomas Engstrøm, MD, PhD, DMSc Copenhagen University Department of Cardiology Rigshospitalet Copenhagen Bindet til HjerteStatistik
More informationTicagrelor vs prasugrel in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
DISCLOSURES: NONE Ticagrelor vs prasugrel in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention I. Xanthopoulou, KC. Theodoropoulos, G. Kassimis, V.
More informationEffective Health Care Program
Comparative Effectiveness Review Number 66 Effective Health Care Program Treatment Strategies for Women With Coronary Artery Disease Executive Summary Background Cardiovascular disease remains the leading
More informationREFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO
REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients
More informationSurgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome
Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures
More informationQuality and Reporting Characteristics of Network Meta-analyses: A Scoping Review
Quality and Reporting Characteristics of Network Meta-analyses: A Scoping Review Andrea C. Tricco MSc, PhD Scientist, Li Ka Shing Knowledge Institute of St. Michael s Hospital Assistant Professor, Dalla
More informationSTATINS EVALUATION IN CORONARY PROCEDURES AND REVASCULARIZATION
STATINS EVALUATION IN CORONARY PROCEDURES AND REVASCULARIZATION Otávio Berwanger, MD, FACS - On behalf of the SECURE Steering Committee and Investigators Trial Organization Trial Steering Committee Dr.
More informationST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set
Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not
More informationFrans Van de Werf, MD, PhD Leuven, Belgium
STEMI Cases and the ESC STEMI Guidelines Frans Van de Werf, MD, PhD Leuven, Belgium The Easy Case 2/21/2011 History and Risk Factors 50-year old male patient Past medical history: Teratoma right testis
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA152 drug-eluting stents for the treatment of coronary artery disease (part review of TA71) this guidance was originally
More informationCritics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS
Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner
More informationRural Minnesota STEMI Systems of Care
CARDIOVASCULAR HEALTH UNIT Rural Minnesota STEMI Systems of Care Almost 250,000 Americans experience ST-elevation Myocardial Infarction (STEMI), the deadliest form of heart attack, each year. Of approximately
More informationMISTRAL. Myocardial Infarction with ST-elevation Treated by Primary Percutaneous Intervention Facilitated by Early Reopro Administration in ALsace
Les Hôpitaux Universitaires de STRASBOURG MISTRAL Myocardial Infarction with ST-elevation Treated by Primary Percutaneous Intervention Facilitated by Early Reopro Administration in ALsace Pre-hospital
More informationSTEMI Care 2014 at the Crossroads: Taking the right road
STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,
More informationClinical Policy Bulletin: Remote Ischemic Conditioning
Remote Ischemic Conditioning Page 1 of 15 Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Clinical Policy Bulletin: Remote Ischemic Conditioning Revised April
More information1/24/2018. Taking Mechanical CPR to New Heights: Use of Automated Chest Compression Devices in Helicopter EMS Transport.
Taking Mechanical CPR to New Heights: Use of Automated Chest Compression Devices in Helicopter EMS Transport NAEMSP 2018 Annual Meeting January 8-13, 2018 San Diego, CA John W. Lyng, MD, FACEP, FAEMS,
More informationDATE: 06 June 2012 CONTEXT AND POLICY ISSUES
TITLE: Clopidogrel, Prasugrel and Ticagrelor in Adults with Acute Coronary Syndrome: A Review of the Clinical Effectiveness, Cost Effectiveness and Guidelines DATE: 06 June 2012 CONTEXT AND POLICY ISSUES
More informationBMJ Open. Cardiovascular medicine
BMJ Open Remote ischaemic conditioning, pre-infarction angina and coronary collateral blood flow in patients with ST-segment elevation myocardial infarction Journal: BMJ Open Manuscript ID bmjopen--0 Article
More informationINDIVIDUALIZED MEDICINE
CENTER FOR INDIVIDUALIZED MEDICINE Clopidogrel Pharmacogenetics Can We Impact Clinical Practice? Michael E. Farkouh, MD, MSc Peter Munk Cardiac Centre University of Toronto Naveen Pereira MD Mayo Clinic
More informationTime of onset and predictors of biphasic anaphylactic reactions: A systematic. A. To describe the time frame where biphasic reactions can occur.
KER UNIT - PROTOCOL OF REVIEW TITLE Time of onset and predictors of biphasic anaphylactic reactions: A systematic review and meta-analysis of the literature REVIEW QUESTION A. To describe the time frame
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationWhat is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN
What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN October 2011 Part 2 Summary of newer antithrombotic and antiplatelet agents in STEMI Role of thrombectomy in PPCI
More informationParamedic CAT (Critically Appraised Topic) Worksheet
Paramedic CAT (Critically Appraised Topic) Worksheet Title: Manual CPR Vs. Mechanical CPR Report By: Meghan Beals 2 nd Party Appraiser: Clinical Scenario: You are called to the home of a 65 year old female
More informationAlcohol interventions in secondary and further education
National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods
More informationLow Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)
Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Caitlin C. Akerman, PharmD PGY2 Cardiology Resident WakeMed Health & Hospitals Raleigh,
More informationMeet the Guidelines Le principali novità che modificheranno la nostra pratica clinica: STEMI
Meet the Guidelines 2017. Le principali novità che modificheranno la nostra pratica clinica: STEMI Guido Parodi Cardiologia Interventistica AOU Sassari Scuola di Specializzazione in Malattie dell Apparato
More informationDecision for fibrinolysis or primary PCI in the prehospital phase
Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,
More informationST Elevated Myocardial Infarction- Latest AHA recommendations
ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to
More informationSTREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve
STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION PCI Hospital Ambulance/ER STREAM design STEMI
More informationOptimal antithrombotic therapy:
Optimal antithrombotic therapy: upstream and during primary PCI. Steen D Kristensen, MD, DMSc, FESC Professor and Consultant Interventional Cardiologist Aarhus University, Denmark UNIVERSITY OF AARHUS
More informationMaximising Delivery of Thrombectomy
Maximising Delivery of Thrombectomy Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor of Clinical
More informationFrom interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
More informationIQWiG Reports - Commission No. A Ezetimibe for hypercholesterolaemia 1. Executive Summary
IQWiG Reports - Commission No. A10-02 Ezetimibe for hypercholesterolaemia 1 Executive Summary 1 Translation of the executive summary of the final report Ezetimib bei Hypercholesterinämie (Version 1.0;
More informationPrimary Angioplasty for the Treatment of Acute ST- Segment Elevated Myocardial Infarction
Ontario Health Technology Assessment Series 2004; Vol. 4, No. 10 Primary Angioplasty for the Treatment of Acute ST- Segment Elevated Myocardial Infarction An Evidence-Based Analysis August 2004 Medical
More informationCAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL?
CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? Mette Nørgaard, Professor, MD, PhD Department of Clinical Epidemiology Aarhus Universitety Hospital Aarhus, Denmark Danish Medical Birth Registry
More informationMULTIcentre evaluation of Single high-dose. acute myocardial infarction study
MULTIcentre evaluation of Single high-dose Tirofiban bolus TiRofiban vs. versus with sirolimus eluting stent or barein metal stent in during primary PCI STEMI acute myocardial infarction study M. Valgimigli,
More informationTrial Update- TOTAL. Jonathan Byrne
Trial Update- TOTAL Jonathan Byrne No conflicts of interest Background- rationale for thrombectomy Major Limitation of primary PCI: distal embolisation and reduced flow Stonel JACC 2002;39:591-7 Henriques
More informationThe Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:
The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI
More informationFeng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor
Feng-Yi Lai, RN, MSN, Instructor Department of Nursing, Shu-Zen College of Medicine and Management, Asphodel Yang, RN, PhD, Associate Professor Department of Nursing, Central Taiwan University of Science
More informationPneumococcal polysaccharide vaccines: Systematic review and meta-analysis of randomised controlled efficacy trials
Pneumococcal polysaccharide vaccines: Systematic review and meta-analysis of randomised controlled efficacy trials Pippa Scott, Anke Huss, Matthias Egger Institute of Social & Preventive Medicine (ISPM)
More informationControversies on Primary angioplasty in STEMI
Controversies on Primary angioplasty in STEMI 원주의대이승환 Case ( 51/M) CC C.C: ongoing squeezing chest pain D : for 2 hours Risk factors Current smoker ( 40 PYs) Hypercholesterolemia (+) Case ( 51/M) Physical
More informationNo-reflow - microvascular obstruction
Disclosures: Research grant from Medtronic to University of Ferrara Ad Board of Abbott, Medtronic, MEDCO, Eli lilly, Iroko Speaker s bureau from Cordis, Abbott, CID Vascular, Terumo, Medtronic, Astra Zeneca,
More informationSupplementary Online Content
Supplementary Online Content Navarese EP, Robinson JG, Kowalewski M, et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationPost-Resuscitation Care. Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena
Post-Resuscitation Care Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena Conflict of interest Emcools Shareholder and founder, honoraria Zoll: honoraria Bard: honoraria, nephew works
More informationClopidogrel vs New Antiplatelet Therapy (Prasugrel) Adnan Kastrati, MD Deutsches Herzzentrum, Technische Universität München, Germany
Clopidogrel vs New Antiplatelet Therapy () Adnan Kastrati, MD Deutsches Herzzentrum, Technische Universität München, Germany Seoul, April 3, 21 Dual Antiplatelet Therapy for Stenting MACE, % 12 1 8 6 In
More informationM. Valgimigli, MD, PhD Swiss Cardiovascular Center Bern, Inselspital, Bern, Switzerland on behalf of the MATRIX Group NCT
Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program M. Valgimigli, MD, PhD Swiss Cardiovascular Center
More informationBB ของอ ม หร อจะส BB ของ CRH
Company LOGO A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure Supattra Bangpa ID 48210616 Kulnipa
More informationAllergen immunotherapy for the treatment of allergic rhinitis and/or asthma
ril 2014 Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma FINAL COMPREHENSIVE RESEARCH PLAN June 2015 Study Team: Systematic Review Unit FINAL COMPREHENSIVE RESEARCH PLAN: Systematic
More informationUniversity of Leipzig Heart Center
Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock Holger
More informationStroke Net Grand Round Webinar
Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology None Unique challenges in brain conditioning Review
More informationTransfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem
Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927
More informationand Treatment in Emergency Care) Trial: Intravenous Glucose, Insulin & Potassium (GIK) in Emergency Medical Services
Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement DuringInitial Assessment and Treatment in Emergency Care) Trial: A Double Blinded Randomized Controlled Trial of Intravenous Glucose,
More information